Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
Date:8/4/2008

ble-for-sale securities 37,919 15,240

Cash provided by (used in)

investing activities 18,062 (1,329)

Financing activities

Repurchases of common stock (21,703) -

Exercise of stock options 181 182

Cash (used in) provided by

financing activities (21,522) 182

Increase (decrease) in cash and cash

equivalents (2,183) 3,492

Cash and cash equivalents at beginning

of period 8,536 7,331

Cash and cash equivalents at end of period $6,353 $10,823

Supplemental disclosure of cash paid during

the period for:

Income taxes, net of refunds $115 $60

Non-cash investing activities:

Unrealized gain (loss) on

available-for-sale securities $11 $(29)

2008

Projected

Reconciliation of projected net loss to projected EBITDA

Projected net loss $(900)

Interest income 2,300

Operating loss (3,200)

Non-cash stock compensation expense 1,400

Depreciation and amortization 1,100

Amortization of software development costs 2,200

Projected pro-forma EBITDA $1,500

Reconciliation of net (loss)

income to EBITDA

Three Months Ended Six Months Ended


'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Arcadia Radiology Medical Group Chooses AMICAS
2. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
3. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
4. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
5. eResearchTechnology Reports Second Quarter 2008 Results
6. SuperGen Reports 2008 Second Quarter Financial Results
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
9. CV Therapeutics Reports 2008 Second Quarter Financial Results
10. Gentiva Reports Strong Second Quarter led by Home Health Segment
11. United Therapeutics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 BioPlus ... leading specialty pharmacies, has an expanded team of ... pharmacy consultants for prescriber offices in their regions, ... , “We have a variety of Regional Pharmaceutical ... those specializing in hepatitis C help prescribers understand ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... 18, 2014 Egenix, Inc. is pleased to announce ... of the Board, to succeed Donald Fresne ; Mr. ... continue as a member of the Board.  In recognition of ... the company over almost twenty years, the Board designated Mr. ... Directors has established a Search Committee to find a suitable ...
(Date:12/17/2014)... Bellingham, Washington, USA (PRWEB) December 16, 2014 ... Kirstin Baum, manager at Philipps- Universität Marburg’s Department ... optics and photonics, in the newly released ... 2015-2016. “And never be too shy to ask ... STEM (science, technology, engineering, and mathematics) occupations ranging ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3
... Corporation (Nasdaq: DNDN ) today announced the ... Association,s (AUA) Annual Meeting in Chicago, as well as ... , ... double-blind, placebo-controlled, multi-center, phase III trial of sipuleucel-T in ...
... April 24 LyondellBasell Industries today announced that ... to Lyondell Chemical Company,s reorganization filing under Chapter ... the European holding company against claims by certain ... AF S.C.A. is a holding company incorporated in ...
... in determining risk for colorectal cancer, the second leading ... Several common genetic markers have been found to be ... that lead to cancer can be much more difficult. ... Research (www.genome.org), scientists have identified a common genetic ...
Cached Biology Technology:Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting 2LyondellBasell Adds Holding Company to Chapter 11 Protection 2Beyond associations: Colorectal cancer culprit found 2
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
(Date:12/3/2014)... Dec. 2, 2014   Marvin Test Solutions ... test solutions for military, aerospace, and manufacturing organizations, ... its successful TS-900 PXI semiconductor test platform ... of high-end systems to customers at a fraction ... to traditional ATE. "Our semiconductor ...
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... Boston, Mass. A computational physicist and a cognitive ... the beginnings of a noninvasive test to evaluate an ... which records electrical activity in the brain, with machine-learning ... percent accuracy in distinguishing between 9-month-old infants known to ...
... cycle, helping sequester significant amounts of carbon. Some algal ... discolor coastal waters and reduce the amount of light ... "red tide," the term "harmful algal blooms" (HABs) was ... biomass can sometimes also turn the ocean waters brown ...
... Cross-disciplinary teams of scientists studying genetic pathways that ... also cause certain forms of congenital heart disease ... muscle that is the leading cause of sudden death ... mutations into mice and successfully treated HCM in the ...
Cached Biology News:Using EEGs to diagnose autism spectrum disorders in infants 2Using EEGs to diagnose autism spectrum disorders in infants 3Brown tide culprit sequenced: Genome of the first of algal bloom species 2Brown tide culprit sequenced: Genome of the first of algal bloom species 3Brown tide culprit sequenced: Genome of the first of algal bloom species 4Cancer-related pathways reveal potential treatment target for congenital heart disease 2Cancer-related pathways reveal potential treatment target for congenital heart disease 3
...
... the formation of phosphodiester bonds in the ... 3' hydroxyl and 5' phosphate termini. The ... which can be performed in 5 minutes ... for this enzyme. A T4 DNA ...
Bovine Renal Artery Smooth Muscle Cells (BRASMC) (>500,000 cells)...
... Finnpipette BioControl is a major step ... complete liquid handling system - with ... tip cone modules. All five single ... modules fit one handle. The lightweight ...
Biology Products: